EMJ GOLD: Pharma news, views and analysis

In this Men's Health Week special, the GOLD team is joined by Peter Baker, Director, Global Action on Men's Health and Chumi Khurana, Global Head, Prostate Cancer Disease Area Stronghold, Janssen Oncology. The two guests reveal what they think are the most pressing issues within men's health today, highlight the importance of awareness campaigns, and comment on the role pharma can play in encouraging men to engage with their health.

In this episode of the podcast, the GOLD team is joined by Eric Bouilloux, Chief Development Officer, Istesso. Helena and Eric discuss his impressive career within the pharmaceutical space, drill down into the potential of immunometabolism in diseases like multiple sclerosis, highlight some tips and tricks for progressing within a chosen career path and review his predictions from his first interview with GOLD in 2019. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Talking to Eric Bouilloux https://www.emg-gold.com/post/podcast-talking-to-eric-bouilloux Vaccines, leadership and blockchain https://www.emg-gold.com/post/podcast-vaccines-leadership-and-blockchain "We've lost the focus that we had on routine vaccination of preventable diseases" https://www.emg-gold.com/post/we-ve-lost-the-focus-that-we-had-on-routine-vaccination-of-preventable-diseases

In this episode, the GOLD team is joined by Natalie Yeadon, Co-Founder and CEO, Impetus Digital, to delve deeper into our recent feature, 'Getting into gamification', Content and Editorial Assistant Jade Williams talks to Natalie about how pharma companies can best implement gamification into their practices and what internal and external benefits they can gain. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Getting into gamification https://www.emg-gold.com/post/getting-into-gamification The reality of the metaverse https://www.emg-gold.com/post/the-reality-of-the-metaverse The difficulties of digital upskilling https://www.emg-gold.com/post/the-difficulties-of-digital-upskilling

In this episode, GOLD speaks to Lenias Hwenda, Founder and CEO, Medicines for Africa, and Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). Following on from GOLD's recent 'Pharma in South Africa' feature, Lenias explains what the implementation of South Africa's new healthcare system will mean for global pharma, as well as exploring genomics and market access. Alexander discusses his interest in pricing and access of pharmaceuticals, shares how value-based reimbursement is evolving and offers his thoughts on the new EU Health Technology Assessment procedure. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Pharma in South Africa https://www.emg-gold.com/post/pharma-in-south-africa Margo Warren on global access to medicine https://www.emg-gold.com/post/podcast-margo-warren-on-global-access-to-medicine Seeking solutions to low income, low access https://www.emg-gold.com/post/seeking-solutions-to-low-income-low-access Operation vaccines: access all areas https://www.emg-gold.com/post/operation-vaccines-access-all-areas

In this special bonus episode, GOLD's Editor Helena Beer reflects on the themes and her own key takeaways from this month's NEXT Pharma Summit. What challenges are facing pharma, and what does the industry need to do to overcome these? Assistant Editor Isabel O'Brien also catches up with the event's founder and chairman Dario Safaric to discuss his event highlights and thoughts on pharma's future. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Digitalisation: moving past paperless https://www.emg-gold.com/post/digitalisation-moving-past-paperless A cautionary tale of innovation https://www.emg-gold.com/post/a-cautionary-tale A silver lining of patient centricity https://www.emg-gold.com/post/a-silver-lining-for-patient-centricity The difficulties of digital upskilling https://www.emg-gold.com/post/the-difficulties-of-digital-upskilling

In this episode, GOLD is joined by Emma Booth, Executive Director, Global Business Process and Insights Lead, R&D Strategy and Operations at Amgen. She discusses medical affairs communication and strategy, the power of data initiatives and the roadblocks that are preventing these from reaching their full potential, plus balancing leadership with nurturing one's own aspirations. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Fresh clarity on RWE integration https://www.emg-gold.com/post/fresh-clarity-on-rwe-integration Standing out in a crowd of content https://www.emg-gold.com/post/standing-out-in-a-crowd-of-content Discussing a new dawn for data https://www.emg-gold.com/post/discussing-a-new-dawn-for-data The RWD revolution https://www.emg-gold.com/post/the-rwd-revolution

In this episode, GOLD is joined by two of the pharmaceutical industry's most unwavering mental health advocates: Wendy Bartie, Senior Vice President, US Oncology, Bristol Myers Squibb, and Courtney Billington, President, Janssen Neuroscience. They discern what resources pharma companies should be making available to their employees, what the industry's role is in supporting patient mental health and how they manage their own mental wellbeing. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Pressure on UK government over mental health https://www.emg-gold.com/post/pressure-on-uk-government-over-mental-health The driving seat of organisational change https://www.emg-gold.com/post/the-driving-seat-of-organisational-change Making a difference in terminal diseases https://www.emg-gold.com/post/making-a-difference-in-terminal-diseases Routine vaccinations: road to recovery https://www.emg-gold.com/post/routine-vaccinations-road-to-recovery

In this episode, Helena is joined by Klaus Legau, Senior Advisor, Social Sustainability at Leo Pharma. Klaus reveals the most important facets of a social sustainability strategy and where he believes the pharmaceutical industry is falling short in this respect, as well as offering expert advice to those starting out in policy campaigning. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: The driving seat of organisational change https://www.emg-gold.com/post/the-driving-seat-of-organisational-change Novartis enhances social mobility commitments https://www.emg-gold.com/post/novartis-enhances-social-mobility-commitments A joint mission for social justice https://www.emg-gold.com/post/a-joint-mission-for-social-justice Setting the stage for a more equitable future https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future

In this episode, GOLD speaks with Luisa Luciani-Silverman, US Medical Head of Immuno-Oncology at AstraZeneca. She discusses all things medical affairs, delving into analytics, evidence generation, hiring candidates from non-traditional backgrounds and much more. Following on from GOLD's recent online poll, the team also hears from some special guests about their take on using TikTok as a pharma marketing tool. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Time to Turn to TikTok? https://www.emg-gold.com/post/time-to-turn-to-tiktok Fresh clarity on RWE integration https://www.emg-gold.com/post/fresh-clarity-on-rwe-integration The uphill recruitment battle https://www.emg-gold.com/post/the-uphill-recruitment-battle The metrics of medical affairs https://www.emg-gold.com/post/the-metrics-of-medical-affairs

In this episode, GOLD is joined by Aaron Grandy, Associate Director, Alira Health, and Co-Founder, Precision Healthcare Consulting, who discusses the aim of his start-up, GoMed, on access and health outcomes in Africa. Plus, Laurence Woollard, Founder and Director, On The Pulse Consultancy, joins the team to explore the haemophilia landscape and share key messages for the pharma industry. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: New TV show brings "voice to voiceless" in Africa https://www.emg-gold.com/post/new-tv-show-brings-voice-to-voiceless-in-africa The rare disease disparity https://www.emg-gold.com/post/the-rare-disease-disparity Seeking solutions to low income, low access https://www.emg-gold.com/post/seeking-solutions-to-low-income-low-access Bridging the digital health divide https://www.emg-gold.com/post/bridging-the-digital-health-divide